 |
 |

Age Range Widens for Pertussis Vaccine
Boosters Advised for Adolescents and Adults
Mike Mitka
JAMA. 2006;295:871-872.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
While most young children in the United States have received vaccinations against Bordetella pertussis since the 1940s, in recent years "whooping cough" has made a comeback.
Many in public health believe an increase in pertussis cases over the past decade is partially the result of waning immunity 5 to 10 years after vaccination, leaving adolescents particularly vulnerable and creating a potential reservoir of infection in adults. This pertussis reservoir in turn increases the risk of disease transmission to highly vulnerable unvaccinated newborns. The approval in 2005 of two new combination booster vaccines means that now almost all adolescents and adults will be able to be protected against pertussis infection.
Since 1976, when a low of 1060 cases were reported, pertussis prevalence has risen to a reported 40-year high of 25 000 in 2004, with an estimated one third of all cases occurring in adolescents. Deaths among infants from pertussis . . . [Full Text of this Article] ACELLULAR VACCINE
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|